Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 in Multiple Myeloma
NCT07154537Phase 4Active, not recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Mar 2016
- Primary completion
- Apr 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Prevnar 13 in pneumococcal infection, sponsored by National Taiwan University Hospital. Started Mar 2016; status: active, not recruiting.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT07154537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07154537.